Page last updated: 2024-08-16

piracetam and neuropeptide y (13-36)

piracetam has been researched along with neuropeptide y (13-36) in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Foti, S; Gallagher, M; Haberman, RP; Koh, MT; McCown, TJ	1

Other Studies

1 other study(ies) available for piracetam and neuropeptide y (13-36)

Article	Year
Treatment strategies targeting excess hippocampal activity benefit aged rats with cognitive impairment. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010, Volume: 35, Issue:4 Topics: Age Factors; Aging; Animals; Anticonvulsants; CA3 Region, Hippocampal; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Levetiracetam; Male; Maze Learning; Neuropeptide Y; Peptide Fragments; Piracetam; Rats; Rats, Long-Evans; Space Perception; Transduction, Genetic; Valproic Acid	2010

Article

Year

Treatment strategies targeting excess hippocampal activity benefit aged rats with cognitive impairment.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010, Volume: 35, Issue:4

Topics: Age Factors; Aging; Animals; Anticonvulsants; CA3 Region, Hippocampal; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Levetiracetam; Male; Maze Learning; Neuropeptide Y; Peptide Fragments; Piracetam; Rats; Rats, Long-Evans; Space Perception; Transduction, Genetic; Valproic Acid

2010